Cone-Rod Dystrophy
Symptoms, Doctors, Treatments, Advances & More

Learn About Cone-Rod Dystrophy

What is the definition of Cone-Rod Dystrophy?

Cone-rod dystrophy is a group of related eye disorders that causes vision loss, which becomes more severe over time. These disorders affect the retina, which is the layer of light-sensitive tissue at the back of the eye. In people with cone-rod dystrophy, vision loss occurs as the light-sensing cells of the retina gradually deteriorate.

What are the causes of Cone-Rod Dystrophy?

Mutations in more than 30 genes are known to cause cone-rod dystrophy. Approximately 20 of these genes are associated with the form of cone-rod dystrophy that is inherited in an autosomal recessive pattern. Mutations in the ABCA4 gene are the most common cause of autosomal recessive cone-rod dystrophy, accounting for 30 to 60 percent of cases. At least 10 genes have been associated with cone-rod dystrophy that is inherited in an autosomal dominant pattern. Mutations in the GUCY2D and CRX genes account for about half of these cases. Changes in at least two genes cause the X-linked form of the disorder, which is rare.

How prevalent is Cone-Rod Dystrophy?

Cone-rod dystrophy is estimated to affect 1 in 30,000 to 40,000 individuals.

Is Cone-Rod Dystrophy an inherited disorder?

Cone-rod dystrophy is usually inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top Cone-Rod Dystrophy Local Doctors?
Elite in Cone-Rod Dystrophy
Ophthalmology
Elite in Cone-Rod Dystrophy
Ophthalmology
Referral may be required

UPMC Vision Institute

1622 Locust Street, Floor 2, 
Pittsburgh, PA 
Languages Spoken:
English, French
Accepting New Patients
Offers Telehealth

Jose' Sahel is an Ophthalmologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Sahel is rated as an Elite provider by MediFind in the treatment of Cone-Rod Dystrophy. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, X-Linked Congenital Stationary Night Blindness, Retinitis Pigmentosa, and Vitrectomy. Dr. Sahel is currently accepting new patients.

Elite in Cone-Rod Dystrophy
Ophthalmology
Elite in Cone-Rod Dystrophy
Ophthalmology
Referral may be required

Scheie Eye Institute Perelman

3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients

Tomas Aleman is an Ophthalmologist practicing medicine in Philadelphia, Pennsylvania. Dr. Aleman is rated as an Elite provider by MediFind in the treatment of Cone-Rod Dystrophy. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Choroideremia, Leber Congenital Amaurosis, Retinopathy Pigmentary Mental Retardation, and Cone-Rod Dystrophy. Dr. Aleman is board certified in Ophthalmology, 2019. Dr. Aleman is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cone-Rod Dystrophy
Elite in Cone-Rod Dystrophy
Referral may be required
Paris, FR 

Christina Zeitz practices practicing medicine in Paris, France. Ms. Zeitz is rated as an Elite expert by MediFind in the treatment of Cone-Rod Dystrophy. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses X-Linked Congenital Stationary Night Blindness, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, Late-Onset Retinal Degeneration, and Vitrectomy.

What are the latest Cone-Rod Dystrophy Clinical Trials?
Foundation Fighting Blindness My Retina Tracker Registry

Summary: The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by the Foundation. It is a patient-initiated registry accessible via a secure on-line portal at www.MyRetinaTracker.org. Affected individuals who register are guided to create a profile that captures their perspective on the...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Adaptive Optics Imaging of Outer Retinal Diseases

Summary: The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.

Who are the sources who wrote this article ?

Published Date: March 01, 2018
Published By: National Institutes of Health